Topics
Glioblastoma | Treatment | Drug delivery
Home > Publications > Topics > Glioblastoma > Treatment > Drug delivery
Intra-arterial cerebral infusion
Bukhari SS, Ahmed N, Shamim MS.
Super
selective intra-arterial cerebral infusion (SSIACI) for newly
diagnosed and recurrent glioblastoma.
J
Pak Med Assoc. 2024 Jun 28;74(7):1380-1381. doi:
10.47391/JPMA.24-55. PMID:
39028079. Review. ˍ
Therapeutic Agents
Rolfe NW, Dadario NB, Canoll P, Bruce JN.
A
Review of Therapeutic Agents Given by Convection-Enhanced Delivery
for Adult Glioblastoma.
Pharmaceuticals
(Basel). 2024 Jul 23;17(8):973. doi:
10.3390/ph17080973. PMID:
39204078. Review. ˍ
Nanocarriers
Firuzpour F, Saleki K, Aram C, Rezaei N.
Nanocarriers
in glioblastoma treatment: a neuroimmunological perspective.
Rev
Neurosci. 2024 Dec 30. doi:
10.1515/revneuro-2024-0097. PMID:
39733347. Review˰ ˍ
Nose-to-Brain Delivery
Agnihotri TG, Dahifale A, Gomte SS, Rout B, Peddinti V, Jain A.
Nanosystems
at Nexus: Navigating Nose-to-Brain
Delivery for Glioblastoma Treatment.
Mol
Pharm. 2025 Jan 2. doi:
10.1021/acs.molpharmaceut.4c00703. PMID:
39746097. Review˰
ˍ
Convection-Enhanced Delivery
Mokarram N, Case A, Hossainy NN, Lyon JG, MacDonald TJ,
Bellamkonda R.
Device-assisted
strategies for drug delivery across the blood-brain barrier to
treat glioblastoma.
Commun
Mater. 2025 Jan 7;6(1):5. doi:
10.1038/s43246-024-00721-y. PMID:
39790893. Review. ˍ